DE3766514D1 - 1,2,3,4-tetrahydro-6-substituierte-4-aryl(oder heterocyclo)-3-substituierte-2-thioxo(oder oxo)-5-pyrimidincarboxylsaeuren und -ester. - Google Patents

1,2,3,4-tetrahydro-6-substituierte-4-aryl(oder heterocyclo)-3-substituierte-2-thioxo(oder oxo)-5-pyrimidincarboxylsaeuren und -ester.

Info

Publication number
DE3766514D1
DE3766514D1 DE8787102922T DE3766514T DE3766514D1 DE 3766514 D1 DE3766514 D1 DE 3766514D1 DE 8787102922 T DE8787102922 T DE 8787102922T DE 3766514 T DE3766514 T DE 3766514T DE 3766514 D1 DE3766514 D1 DE 3766514D1
Authority
DE
Germany
Prior art keywords
substituted
heterocyclo
thioxo
tetrahydro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787102922T
Other languages
English (en)
Inventor
Karnail Atwal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/839,770 external-priority patent/US4684655A/en
Priority claimed from US06/840,130 external-priority patent/US4684656A/en
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of DE3766514D1 publication Critical patent/DE3766514D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
DE8787102922T 1986-03-14 1987-03-02 1,2,3,4-tetrahydro-6-substituierte-4-aryl(oder heterocyclo)-3-substituierte-2-thioxo(oder oxo)-5-pyrimidincarboxylsaeuren und -ester. Expired - Fee Related DE3766514D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/839,770 US4684655A (en) 1986-03-14 1986-03-14 1,2,3,4-tetrahydro-6-substituted-4-aryl-3-substituted-2-thioxo(or oxo)-5-pyrimidinecarboxylic acids and esters and use thereof to lower blood pressure
US06/840,130 US4684656A (en) 1986-03-14 1986-03-14 1,2,3,4-tetrahydro-6-substituted-4-aryl-3-(substituted sulfonyl)-2-thioxo(or oxo)-5-pyrimidinecarboxylic acids and esters and method of using them to lower blood pressure

Publications (1)

Publication Number Publication Date
DE3766514D1 true DE3766514D1 (de) 1991-01-17

Family

ID=27126139

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787102922T Expired - Fee Related DE3766514D1 (de) 1986-03-14 1987-03-02 1,2,3,4-tetrahydro-6-substituierte-4-aryl(oder heterocyclo)-3-substituierte-2-thioxo(oder oxo)-5-pyrimidincarboxylsaeuren und -ester.

Country Status (7)

Country Link
EP (1) EP0236902B1 (de)
AU (1) AU598793B2 (de)
CA (1) CA1275410C (de)
DE (1) DE3766514D1 (de)
DK (1) DK131087A (de)
HU (1) HUT43831A (de)
NZ (1) NZ219299A (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81800A0 (en) * 1986-03-14 1987-10-20 Squibb & Sons Inc 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-((substituted amino)carbonyl)-2-thioxo(or oxo)-5-pyrimidine-carboxylic acids and esters and pharmaceutical compositions containing the same
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
PL320263A1 (en) * 1994-11-16 1997-09-15 Synaptic Pharma Corp Dihydropyrimidines and their application
US6228861B1 (en) 1995-11-16 2001-05-08 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6245773B1 (en) 1996-05-16 2001-06-12 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6172066B1 (en) 1996-05-16 2001-01-09 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6143750A (en) * 1997-06-18 2000-11-07 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6214832B1 (en) 1997-06-18 2001-04-10 Merck & Co., Inc. Bis-piperidinyl-pyrimidin-2-ones as alpha 1a adrenergic receptor antagonists
US6080760A (en) * 1997-06-18 2000-06-27 Merck & Co., Inc. Alpha 1A adrenergic receptor antagonists
US6376503B1 (en) 1997-06-18 2002-04-23 Merck & Co., Inc Alpha 1a adrenergic receptor antagonists
US6057350A (en) * 1997-06-18 2000-05-02 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6339099B1 (en) 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
US6680323B2 (en) 1998-12-23 2004-01-20 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6274585B1 (en) 1998-12-23 2001-08-14 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6720324B2 (en) 2000-07-05 2004-04-13 Synaptic Pharmaceutical Corporation Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
US7166603B2 (en) 2003-07-23 2007-01-23 Bristol-Myers Squibb Co. Dihydropyrimidone inhibitors of calcium channel function
WO2005007124A2 (en) 2003-07-23 2005-01-27 Bristol-Myers Squibb Company Substituted dihydropyrimidine inhibitors of calcium channel function

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
US4041035A (en) * 1976-06-08 1977-08-09 Morton-Norwich Products, Inc. 1-Benzyl-1,2-dihydro-3-methyl-2-oxopyrimidinium iodide
US4609494A (en) * 1985-02-21 1986-09-02 Merck & Co., Inc. 5-acetyl-3,4,5,6-tetrahydro-4-oxo-2,6-methano-2H-1,3,5-benzothiazocine(benzodiazocine)-11-carboxylates useful as calcium channel blockers

Also Published As

Publication number Publication date
EP0236902B1 (de) 1990-12-05
AU598793B2 (en) 1990-07-05
DK131087A (da) 1987-09-15
NZ219299A (en) 1989-01-06
HUT43831A (en) 1987-12-28
CA1275410C (en) 1990-10-23
DK131087D0 (da) 1987-03-13
EP0236902A1 (de) 1987-09-16
AU6927087A (en) 1987-09-17

Similar Documents

Publication Publication Date Title
FI842114A (fi) Pressparti med separata presszon i en pappersmaskin.
DE3766514D1 (de) 1,2,3,4-tetrahydro-6-substituierte-4-aryl(oder heterocyclo)-3-substituierte-2-thioxo(oder oxo)-5-pyrimidincarboxylsaeuren und -ester.
DE68904679T2 (de) Elektroplattierung von kleinen partikeln.
FI902904A0 (fi) Nmr-maetkropp med flera isolerade i plan liggande ytspolar.
DE3770661D1 (de) 1,2,3,4-tetrahydro-6-substituierte-4-aryl(oder heterozyklo)3-((substituierte amino)carbonyl)-2-thioxo(oder oxo)-5-pyrimidinkarbonsaeuren und -ester.
FI884869A (fi) I samband med blodprovtagning anvaendbart plaoster.
FI885079A0 (fi) Speciellt med klorhexadin kompatibel kiseloxid foer anvaendning i tandkraemskompositioner.
FI875397A0 (fi) Substituerade aminometyl-5,6,7,8 -tetrahydronaftyl-oxiaettikasyror, nya mellanprodukter, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel.
FI890587A (fi) Reaktorkammare i en reaktor med fluidiserad baedd.
FI873060A (fi) Modifierad vaevnads-plasmin-aktivator.
FR2593538B1 (fr) Veture perfectionnee.
FI861940A (fi) Stoedanordning foer nackstycket i en borrmaskin.
FI895989A0 (fi) Triazinoligomerestrar- och amider med en tetrametylpiperidylgrupp i aendstaellning.
DE3675838D1 (de) 5-chloro-s-triazolo(4,3-a)pyridin-7-carbonsaeuren.
FI900932A (fi) Minnesdosa foer anvaendning i samband med tv-spelmaskin.
FI861927A0 (fi) Laosmekanism foer styranordningen i en elbrytare.
FI902281A0 (fi) Inlaerningsprosessystem foer anvaendning i en databehandlingsapparat med naetstruktur.
FI864808A0 (fi) Klaem- och fastspaenningsanordning foer okvistat virke (med kvistar) i kombination med en virkestransportbanke.
ES2012810B3 (es) Persiana-toldo perfeccionada.
IT8618806V0 (it) Lava - pentole n.2
ATE64388T1 (de) 1,2,3,4-tetrahydro-6-substituierte-4-aryl(oder heterozyklo)3-((substituierte amino)carbonyl>-2- thioxo(oder oxo)-5-pyrimidinkarbonsaeuren und - ester.
ATE91548T1 (de) Biosensoren.
ES283521Y (es) Prenda perfeccionada.
FI883065A0 (fi) Se ansoekning 854577.
NO874300D0 (no) Festeanordning.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee